March 13, 2013 at 14:29 PM EDT
UPDATE: Stifel Downgrades Geron from Hold to Sell
Stifel Nicolaus' Brian Klein downgraded shares of Geron (NASDAQ: GERN ) from Hold to Sell in an intraday research note. Related to Imetelstat rests trial, the analyst said, "While management states that this is the most expedited way to derive the clinical data necessary for future company-sponsored trials, we view this development
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays. Stock Market Holiday List
By accessing this page, you agree to the following
Press Release Service provided by PRConnect.
Stock quotes supplied by Telekurs USA
Postage Rates Bots go here